The Scientist - Home

Photo: Courtesy of King Pharmaceuticals OLD DRUG, NEW USES: Ace inhibitor ALTACE Clinical trials are under way in the United States to test new uses for angiotensin I-converting enzyme (ACE) inhibitors, as lab researchers around the world continue to compile evidence of further possibilities for the antihypertensive drugs. Meanwhile, a paper to be published this month presents a detailed theory that ACE functions at the start of a signaling pathway common to major diseases that are other

Photo: Courtesy of NASA ON THE HORIZON: New technologies will protect the health of astronauts on long space flights. Researchers at the National Space Biomedical Research Institute (NSBRI) are developing technologies to identify and monitor anticipated and unanticipated microorganisms in space--technologies, they suggest, that could also help to more efficiently diagnose medical conditions down here on Earth, as well as help detect biological hazards in this post-Sept. 11 world.1-3 Geo

File photo It is a sobering time for US stem cell researchers. Just days after a national election set the stage for the possible criminalization of embryonic stem cell research, a popular television program portrayed such cells incubating in patients in coma, ready to be used to treat a wealthy man's Parkinson disease. A video presented at the American Society for Human Genetics annual meeting in Baltimore a month earlier, however, told a very different story--this one real. The video showed

Founding father of organ transplantation dies, aged 81.

Australian Senate passes stem cell legislation and bans human cloning.

Canadian Supreme Court rules higher life form is not an invention.

Funds will flow soon, say research agencies at 2003 biodefense funding conference.

Germany's public research bodies respond angrily to sudden government austerity measures.

Human tissues collected by anthropologists provoke increasing controversy.

Public mouse sequence will cool the already waning gene patent frenzy.

With publication of the mouse genome sequence come tantalizing glimpses of its huge importance.

Report finds weaknesses in CDC supervision of select agents in US labs.